View all OncoLogue CME

Share a PER® activity with your colleagues or friends. Connect with the PER® social network.



Accreditation/ Credit Designation

Physicians' Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC, designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Resources

PER Pulse™ Recap
OncoLogue Case Discussions™:  Smoldering Myeloma: To Treat or Not to Treat?, is an interactive, video-based, online CME activity that features 3 case presentations and discussions by myeloma experts Drs. C. Ola Landgren, Irene Ghobrial, and Neha Korde. The cases presented in this activity highlight contemporary issues confronted by hematologists who provide care for patients with monoclonal gammopathy of undetermined significance (MGUS), smoldering multiple myeloma (SMM), and symptomatic MM.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from Amgen.


OncoLogue Case Discussions™: Smoldering Myeloma: To Treat or Not to Treat?


Release Date: June 22, 2016
Expiration Date: June 22, 2017
Media: Internet - based

Activity Overview

This Oncologue case discussion features a panel of experts in myeloma addressing real-world clinical scenarios and best practices involving diagnosis and risk stratification of monoclonal gammopathy of unknown significance, smoldering myeloma, and symptomatic myeloma. The faculty also reviews and discusses current and emerging management options for smoldering myeloma. Throughout the activity, the panel provides evidence-based perspectives and guidance to help clinicians integrate guidelines and new data into practice.

CME Activity Table of Contents

  • Introduction
  • Identification of Smoldering Myeloma
  • Emerging Management Options for Smoldering Myeloma
  • Risk of Progression from Smoldering to Active Myeloma
  • Key Takeaways & Sources

Instructions For This Activity & Receiving Credit

  • You will need to login to participate in the activity.
  • Each presentation may contain an interactive question(s). You may move forward through the presentation; however, you may not go back to change answers or review videos/content until you finish the presentation.
  • At the end of the activity, "educational content/video" will be available for your reference.
  • In order to receive a CME certificate, participants must complete the activity.
  • Complete the posttest and pass with a score of 70% or higher, complete the evaluation and then click on request for credit. Participants may immediately download a CME certificate upon completion of these steps.


Target Audience

This activity is intended for hematologists/oncologists. Nurse practitioners, nurses, specialty pharmacists and other healthcare professionals involved in the education, management, and treatment of patients with myeloma will may also participate.

Educational Objectives

At the conclusion of this activity, you should be better prepared to:
  • Review current diagnostic criteria for monoclonal gammopathy of undetermined significance, smoldering multiple myeloma (SMM), and symptomatic myeloma
  • Describe evidence-based strategies for risk stratification and risk-based management of SMM
  • Discuss evolving options to optimize management strategies for patients with high-risk SMM

Faculty, Staff, and Planners' Disclosures

Faculty

(Moderator)
C. Ola Landgren, MD, PhD

Chief, Myeloma Service
Memorial Sloan Kettering Cancer Center
Professor of Medicine, Weill Cornell Medical College
New York, NY
Disclosure: No relevant financial relationships with commercial interests.


Irene Ghobrial, MD
Director, Michele & Steven Kirsch Laboratory
Senior Physician
Associate Professor of Medicine, Harvard Medical School
Boston, MA
Disclosure: Consultant: Novartis, BMS, Celgene, Takeda, Amgen.
 

Neha Korde, MD
Assistant Attending Physician
Myeloma Service
Memorial Sloan Kettering Cancer Center
Assistant Professor of Medicine, Weill Cornell Medical College
New York, NY
Disclosure: No relevant financial relationships with commercial interests.


The following individuals have no relevant financial relationships with commercial interests:

The staff of PER®, LLC.

Disclosure Policy and Resolution of Conflicts of Interest (COI)

It is the policy of Physicians' Education Resource®, LLC, (PER®) to ensure fair balance, independence, objectivity, and scientific rigor in all of our CME activities. In accordance with ACCME guidelines, PER® requires everyone who is in a position to control the content of an educational activity, including spouses/partners, to disclose all relevant financial relationships with any commercial interest to participants as a part of the activity planning process. PER® has implemented mechanisms to identify and resolve all conflicts of interest prior to release of this activity.

Off-Label Disclosure and Disclaimer

This CME activity may or may not discuss investigational, unapproved, or off-label uses of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME activity is for continuing medical education purposes only, and is not meant to substitute for the independent medical judgment of a physician or nurse relative to diagnostic, treatment, or management options for a specific patient's medical condition.

The opinions expressed in the content are solely those of the individual faculty members, and do not reflect those of Physicians' Education Resource®, LLC, or any of the companies that provided commercial support for this activity.

Hardware And Software Requirements

Supported Browsers
Internet Explorer v.7 or greater (for Windows) | Mozilla Firefox v.2 or greater (for Windows, Mac, Linux)

Minimum System Requirements (Windows)
  • A Pentium-based PC or compatible computer
  • At least 64MB of RAM
  • Windows 95/98/NT/ME/2000/XP/Vista system software
  • Screen resolution of 1024 x 786 or larger recommended
  • PDF Reader: Adobe Reader 5.0 or higher, Foxit Reader 2.0 or likewise
Minimum System Requirements (Mac OS)
  • A PowerPC processor-based Macintosh computer
  • At least 64MB of RAM
  • Mac OS 7.5 or later
  • Screen resolution of 1024 x 786 or larger recommended
  • PDF Reader: Adobe Reader 5.0 or higher, Foxit Reader 2.0 or likewise




Calendar of Events
Filter By